Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Rapid Micro Bioysystems, a developer of rapid microbial detection, has raised $32.6 million in a Series B round. According to the Bedford, Mass., company, which makes rapid microbial detection for use in quality control testing for pharmaceuticals, biotech and personal care markets, the funding will be used to expand the commercial and manufacturing operations of its Growth Direct System and additonal applications in environmental monitoring, sterility and bioburden testing. The test uses proprietary digital imaging technology that automatically points out microcolonies days earlier than the traditional counting methods. According to Rapid Micro, the system also captures the native fluorescence (autofluorescence) that is emitted by all living cells.
Help employers find you! Check out all the jobs and post your resume.
